Physician

Rebecca B Campen, MD

According to 2025 Medicare claims, Rebecca Campen, MD (NPI: 1023086899) practices dermatology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is CAMPEN DERMATOLOGY, LLC (NPI: 1336463876; TIN: 14-1854684) and primary practice location at 31405-4601.

Campen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,541 traditional Medicare patients, billed 12,608 HCPCS/CPT codes, and received $461,978 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,901 prescription claims across 735 beneficiaries totaling $102,609 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 27 records totaling $554. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $132,302 to $102,609. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$231K$462K2015 Medicare payment: $318,988 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $346,073 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $370,209 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $365,937 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $359,030 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $374,881 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $446,473 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $446,338 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $462,425 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $461,978 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3788,652$318,988
20161,42710,031$346,073
20171,48910,442$370,209
20181,53810,294$365,937
20191,52710,525$359,030
20201,40110,388$374,881
20211,40811,732$446,473
20221,47912,342$446,338
20231,51212,857$462,425
20241,54112,608$461,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$123K$246K2015 Drug cost: $132,302 (USD; Tot_Drug_Cst)2016 Drug cost: $83,422 (USD; Tot_Drug_Cst)2017 Drug cost: $66,536 (USD; Tot_Drug_Cst)2018 Drug cost: $138,733 (USD; Tot_Drug_Cst)2019 Drug cost: $152,688 (USD; Tot_Drug_Cst)2020 Drug cost: $202,972 (USD; Tot_Drug_Cst)2021 Drug cost: $245,719 (USD; Tot_Drug_Cst)2022 Drug cost: $222,777 (USD; Tot_Drug_Cst)2023 Drug cost: $170,847 (USD; Tot_Drug_Cst)2024 Drug cost: $102,609 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154351,097$132,302
20164911,169$83,422
20175481,473$66,536
20186851,795$138,733
20196611,833$152,688
20206581,898$202,972
20217232,005$245,719
20227061,934$222,777
20237261,897$170,847
20247351,901$102,609

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths7991,057$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3392,293$56
11102Biopsy of related skin growth, first growth694892$54
17000Destruction of precancer skin growth, 1 growth1,0191,488$31
17003Destruction of precancer skin growth, 2-14 growths8235,260$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole3179,302$5,674
MetronidazoleMetronidazole1043,101$4,730
Ammonium LactateAmmonium Lactate2126,920$4,007
Clobetasol PropionateClobetasol Propionate762,156$2,611
CiclopiroxCiclopirox812,382$2,456

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$554Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rebecca B. Campen, MD?

Tedicare shows public-source Medicare data for Rebecca B. Campen, MD (NPI 1023086899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rebecca B. Campen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rebecca B. Campen, MD?

Rebecca B. Campen, MD is linked to CAMPEN DERMATOLOGY, LLC (billing NPI 1336463876) in the available physician profile data.

Does Rebecca B. Campen, MD have Open Payments data?

Rebecca B. Campen, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.